Connect with us

Featured

DEA Confirms Several CBD Extracts Are Safely Legal

Published

on

DEA confirms several Extracts of CBD legal

The Drug Enforcement Administration (DEA) of the US has recently issued a statement that clears a big doubt regarding cannabis last Monday, reaffirming the agency’s plans to do more research on cannabis. They further confirmed that a few of CBD-derived products in the market are now totally legal.

Some three years prior, DEA has announced their will to lead an expanded cannabis research campaign by permitting marijuana growers. As of writing, only the University of Mississippi is officially approved as a grower. The institution has penned an exclusive deal as the cannabis supplier for the federal government. They started more than 50 years ago.

Before the Announcement

In August of 2016, DEA stated that it would allow applications for different entities who wish to grow cannabis. This is in response to the legalization of the substance and the subsequent boom in the market.

Federally-funded study proponents requesting for more cannabis supply that resembles dispensary-handed CBD products for consumers and patients became too much for Ole Miss to handle, leading to the decision.

However, not much has changed since. A total of 33 applications have been accepted by the agency but hasn’t gotten around to reviewing any of them, Reuters reported. Scottsdale Research Institute, an applicant from Arizona, got frustrated by their predicament that they requested the federal court to step in earlier this year. They requested the court to compel DEA to process the applications. They further labeled Ole Miss as a sub-par supply.

Change Has Come

DEA finally decided on the applicant’s plight by announcing that the agency is moving forward by handing out notices to entities regarding pending applications for the registry to marijuana manufacture research.

Uttam Dhillon, DEA Acting Administrator, stated that DEA is progressing on the program that adds additional marijuana growers for registration to federally-sanctioned research. They also plant to coordinate with federal agencies relevant to the matter to expedite steps needed for the program.

He further added that DEA supports more studies on marijuana and other related components and as well as more researches to add a wider variety to studies.

The Catch

The decision is not free from conditions, however. Before DEA will grant registration to any application, it says that rules need to roll out regarding the evaluation and overseeing of potential new cultivators.

The agency’s new rules will help evaluate applications to ensure they comply with legal standards and program policies that are relevant to the related laws. The date or time when DEA officially gives their blessings to successful applicants remains unclear.

DEA included in the announcement their findings regarding some CBD products, which they deem are legal. This removes the need for DEA authorization before growing or making such products.

How the Landscape Changed

This new development can be largely attributed to the Agriculture Improvement Act of 2018, wherein the law redefined the federal understanding of marijuana to exclude the hemp variety. Hemp is a cannabis strain that has low or trace amounts of tetrahydrocannabinol (THC), which is the substance responsible for “pot high” in cannabis users.

The law states that hemp and CBD preparations derived from hemp containing no more than 0.3% THC are not included in the list of controlled substances, which DEA confirmed. Now, entities need not secure DEA registration when growing or researching such products.

This change positively affects the CBD industry, particularly it’s rising popularity. However, health claims made by manufacturers on their CBD-infused products will still be strictly criticized by the Food and Drug Administration. Also, state laws, regulations, and restrictions regarding the matter may still apply.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Unregulated Wellness Chemicals Find Acceptance from Americans

Published

on

Americans Reccommended CBD

Americans easily recommend cannabidiol or CBD, even to strangers they meet on an errand or travel. Shops have popped up here and there, selling a broad range of CBD products, from tinctures to gummies to oils and vapes. Even celebrities like Kylie Jenner has endorsed a CBD-infused product, drawing many fans to try it out as well.

CBD is lauded by users for its alleged therapeutic benefits from alleviating anxiety to curing cancer. There are also varying levels of evidence to back up the different claims.

Hitting peak popularity

According to Google Trends data, CBD has hit its peak in the US last May. The search engine giant recorded more than thrice the queries for CBD than Beyoncé.

Cannabidiol is a compound identified as a cannabinoid, which are chemicals found in hemp and marijuana plants. It was largely unknown a couple of years back, but the legalization of hemp as an industrial crop in the 2018 Farm Bill has catapulted CBD to its popularity today.

Hemp is a cousin of marijuana, the substance infamous for being addictive. Both plants are from the same plant species, Cannabis sativa L., but hemp is considered as the safer, non-psychoactive compound of the two.

Although studies regarding CBD are lacking, consumer interest hasn’t dwindled. Manufacturers have already taken the initial steps to experiment with some less popular cannabinoids like CBN or cannabinol. Salespeople find it easy to market cannabinoids since there is still little information about them.

Before CBD, tetrahydrocannabinol or THC was the most recognized cannabinoid, mainly because it causes the high in marijuana. THC levels in cannabis-derived products draw the line between what is legal and what’s not. With hemp becoming legal to grow and process, the US now has its homegrown supply for CBD production.

Lack of official regulation

The Food and Drug Administration (FDA) is yet to provide detailed rules on cannabidiol, including the labeling and quality testing of the many CBD and CBD-infused products out in the market today. As of writing, CBD products are still illegal to sell as dietary supplements and as a food additive, although such product forms are widely sold domestically.

The FDA still has not provided nuanced rules, due in part to the lack of academic research on cannabis. Permission and funding to conduct cannabis studies are limited, and scientists have a hard time securing such provisions.

Ether Blessing, New York University Langone Health researcher, believes that it might take a decade to establish FDA approval of CBD as a drug. She warned that the current condition makes it difficult for consumers to know the quality and CBD content of the product they are buying.

National Academies of Sciences, Engineering, and Medicine published research in 2017 that concludes cannabinoids as a useful substance for chronic pain, nausea, and multiple sclerosis symptoms. It is one of the very few studies made on the compound.

No waiting for Americans

Despite the very little information on CBD, Americans don’t wait for formality to set in, which is why the CBD industry has flourished in a couple of years. With the cracks in the health care system, CBD products have filled the needs of the average consumer. The substance is said to be effective in alleviating several health conditions, including anxiety, nausea, pain, MS, and cancer.

However, the unique way in which cannabidiol is incorporated or sold does not necessarily mean that it is valid or if there is any CBD in the product at all. What retailers do is satisfy the consumer’s curiosity by developing novel ways to market the compound, even at the expense of the buyer.

Much like vitamins and supplements, CBD and other cannabinoids are mostly untested and unregulated, yet many Americans purchase such products. The more or less have the same reasons, such as distrust for pharmaceuticals, lack of medical care access, or curiosity about the new product.

Continue Reading

Featured

Coca Cola Denies Rumors Regarding CBD-infused Product Development

Published

on

Coca Cola

Coca-Cola has no plans to enter the CBD market with its products, dismissing rumors about the company selling beverages incorporated with hemp oil.

Kent Landers, Coca Cola spokesperson, said in an interview with FOX Business that the speculations are not valid. He reiterated that the beverage giant had no intention of joining the CBD craze as what they have stated several times.

The rumors have arisen after a Youtube video of a man popping open a can of Coca Cola and claiming that it is infused with cannabidiol oil, a cannabis leaf extract typically used to alleviate pain without causing a high. The video has since been deleted.

About the video

The Youtube user who made the video, “Gabor the Blind Guy”, claimed to the viewers that he got ahold of the product via his father who allegedly produced capping and bottling machines for several primary food and pharmaceutical companies.

He further stated that his father was contacted by Coca Cola Canada to develop a machine that would produce childproof caps for Coca Cola cans. The company is said to release a new line of products infused with cannabidiol extracts, which are considered as cannabis-based substances as declared by Gabor.

Coca Cola was supposedly looking into a collaboration with Aurora Cannabis, a Canada-based cannabis production company. The beverage powerhouse allegedly eyed the CBD market since it grew in demand, as reported by Bloomberg last September of 2018.

Warren Buffet and Charlie Munger, CEO and Vice-Chair of Berkshire Hathway, respectively, indicated that Coca Cola joining the marijuana industry would not be right. In an interview with FOX Business Liz Claman, the experts said that entering the CBD market will be detrimental to the wholesome image that the company has kept throughout years.

Munger stated during the Berkshire Hathway Annual Shareholders Meeting held in Omaha, Nebraska that going into the cannabis market is a massive mistake for the company. The company’s image does not align with cannabis and its related products.

James Quincey, Coca-Cola CEO, dispelled the speculation in October, declaring that the company does not plan to get into the CBD space at this stage.

More about CBD

Cannabidiol oil has gained significant popularity over the recent years because of the positive reception from users. CBD is now known as an almost magical remedy that cures or alleviates pain, sleeplessness, anxiety, and more. Users claim that CBD is useful in resolving a broad range of health conditions.

However, there is still no formal regulatory framework for CBD from the Food and Drug Administration or FDA, the regulating body that is supposed to safeguard consumers from fake and harmful products. Many advocates, cannabis groups and even members of the House have called on FDA to hasten the process of providing a clear set of guidelines for the use and sale of CBD products.

The only FDA-approved medication out in the market today is Epidiolex, a drug used as an adjunct treatment for intractable epilepsy. It means that other CBD products out in the market today cannot be advertised as medication or food supplements, which makes adds to the confusion regarding the legality of the industry and the products.

Continue Reading

Featured

CBD-Based Wellness and Skincare Products for Newbies

Published

on

Active ingredients in skin care products can take hours of research, and several clinical trials to determine which ones really work. While nature-derived substances are considered safer, some allergies and skin sensitivities can still cause a reaction when using natural remedies.

Cannabidiol or CBD is the latest natural ingredient that has sparked interest in the wellness industry. It is extracted from Cannabis sativa L., the source plant for hemp and marijuana. Many questions arose regarding the application of CBD on skincare: does it work? What are the benefits of using it for wellness and beauty? Does it give a “high” when used, like in marijuana?

To clarify, cannabidiol is derived from the non-psychotropic component of marijuana. It has little to no tetrahydrocannabinol (THC) content, which is the compound responsible for the psychoactive effect of the drug. Several countries have banned CBD products, but most formulations are safe to use and have zero dependency potential.

In terms of skincare benefits, CBD can be used to soothe, calm, and relax the skin. CBD is touted to have anti-inflammatory effects, which makes it a viable cure for acne. It is also believed to bring balance to skin sebum levels, controlling breakouts. CBD, as a plant-based ingredient, is rich in anti-oxidants and reduces wrinkles, roughness, and dull skin.

It might be confusing or intimidating to start on a CBD-based skin regimen. Some factors to take note of when choosing a CBD product for skin care are the method of extraction, packaging, purity and INCI compliance.

Here are some CBD-based skincare products that you can incorporate into your CBD routine.

Cannuka

Cannuka combines CBD oil and Manuka Honey to provide its all-natural skincare solution. Some of their products include CBD Harmonizing Face Cream, CBD Skin Balm, and CBD Calming Eye Balm, which showcase the healing capabilities of both ingredients. The products were created for the purpose of skin therapy.

The company ensures thoughtful harvesting, sustainable sourcing, and quality. Their hemp farms are known to produce quality cannabidiol since 2014. Their Manuka honey is sourced from an established farm in New Zealand.

Populum

For evening skin routine, the Lavender CBD Face Oil from Populum is an excellent choice. It is made of full-spectrum hemp oil and incorporated with lavender to give a calming sense while also working towards reducing signs of aging. The effect is a more youthful and radiant skin after applying during the night.

CBD and lavender are a good combination, which provides antioxidants, and as well as give a soothing effect for an improved mood and wellness.

Lily CBD

Lily CBD is a company that values integrity, safety standards, and paying it forward. Their CBD-infused product, Essential Oil Rollers, is promoted as a gift item for loved ones with a busy schedule. They incorporate full-spectrum cannabidiol in their products and have travel-friendly skincare items that minimize discomfort after a long trip.

Bathing Culture

Bathing’s Cultures CBD product is Dipsea Soak, which is specially formulated to reduce stress and provide a relaxing bath experience.

Fleur Marche

Fleur Marche is known for its informative labeling and transparency of their products. The Starter Kit is their offering for people wanting to start a CBD routine, with products such as Balance Drops, Nite Nite Patch, Luxury Beauty Serum, CBD Mint Truffles, and CBD & Honey Ache and Pain Relief Stick that are best-selling for their effectiveness.

They Call Her Alfie

The premium collagen and certified CBD make They Call Her Alfie products a hit in the market. They offer fast-acting skincare on their Forever Firming Duet Set, which works to rejuvenate and reinvigorate the skin.

Continue Reading

Trending